Alexandra Ahmet

Investigator, CHEO RI

Dr. Alexandra Ahmet is a pediatric endocrinologist and Division Chief for the Endocrinology department at CHEO and an Associate Professor of pediatrics at the University of Ottawa. Dr. Ahmet has a clinical, research and advocacy focus on patient safety with a specific emphasis on adrenal suppression in children. More recently, Dr. Ahmet has also been involved in development, implementation and evaluation of new clinical programs for adolescents with Type 1 Diabetes with a goal of providing regular patient focused education in preparation for transition to adult care, and formal evaluation of quality of life and mental health status.

Email Researcher Other Publications

Research Areas

Diabetes Adrenal Insufficiency Endocrinology

Research Projects

  1. Control-IQ Technology Positively Impacts Patient Reported Outcome Measures and Glycemic Control in Youth with Type 1 Diabetes in a Real-World Setting

    12/04/2023

    Initiation of Control-IQ technology in a real-world setting significantly reduced the impact of diabetes on daily life while simultaneously improving glycemic control

  2. Patient and family perspective of a Pre-Transition Visit in a pediatric tertiary care diabetes clinic

    31/01/2022

    Overall, we found that both patients and their families had high levels of satisfaction with the Pre-T Visit which reinforced this as a good use of resources (ie, patient, administrative and educator time) in our clinic, with respect to the patient experience. These findings were consistent across patients despite differences in age, gender, diabetes duration and A1C. Furthermore, patients reported high levels of engagement/participation in the visit.

  3. Risk of Hypothyroidism After Administration of Iodinated Contrast Material in Neonates: Are You Aware?

    01/05/2021

  4. The impact of limited and strategic blood glucose monitoring on metabolic control in a type 1 diabetes clinic in Central India

    01/05/2020

    This study assessed whether the use of two SMBG tests per day improves glycemic control, measured by a change in HbA1c, in youth with T1D followed at the DREAM Trust (DT) in Nagpur, India.

  5. Adrenal suppression from glucocorticoids: preventing an iatrogenic cause of morbidity and mortality in children

    29/10/2019

    The intent of this review is to draw attention to this important entity and to allow the reader to create an informed and practical approach to the management of their patients at risk.